Vivek Ramaswamy's company spent $70K lobbying Washington on Covid-19 drugs. He's now campaigning against 'Covid ideology.'
Roivant Sciences paid Baker Donelson and Tiber Creek Group $70,000 to lobby the White House and NIH on Covid drug approval as Ramaswamy now attacks Acton's pandemic record.

























